Switch to:
More From Other Websites
4 Drug Stocks Poised to Surprise this Earnings Season Jan 20 2017
Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : VRTX-US :... Jan 20 2017
Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017 Jan 20 2017
Seaport traffic gets dose of relief as Vertex joins shuttle program Jan 19 2017
Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential Jan 19 2017
Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat? Jan 19 2017
Blog Coverage Paratek Announced Enrollment Completion in Omadacycline Phase-3 Community-Acquired... Jan 19 2017
Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen Jan 18 2017
Concert Offers Update on Cystic Fibrosis Drug, Stock Down Jan 18 2017
Why Vertex Pharmaceuticals (VRTX) Could Be Positioned for a Surge Jan 18 2017
Merck KGaA, Vertex Announce Tie-Up for Oncology Programs Jan 12 2017
Vertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : January 11, 2017 Jan 11 2017
Vertex deals cancer drug programs to Merck KGaA for $230M Jan 11 2017
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement Jan 11 2017
Merck KGaA, Darmstadt, Germany Licenses Four Oncology Research and Development Programs from Vertex Jan 11 2017
Merck KGaA, Darmstadt, Germany Licenses Four Oncology Research and Development Programs from Vertex Jan 11 2017
Jefferies Has 5 Top Biotech Stocks to Buy for 2017 Jan 10 2017
Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US :... Jan 10 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK